Jeff Duncan
Executive Officer at Reprise Biomedical.
Earliest Form D on file: May 2026
2 filings at 1 company
Reprise Biomedical
Biotech, Plymouth MN
Executive Officer
- Signed
- Named
- AmendmentAmendment of an earlier filing
- Size is amount sold, up to $30M
Network
At Reprise Biomedical
12 peopleExecutive Officer, Director, signed as Chief Executive Officer
Director
Director
Executive Officer
Executive Officer
Director